CytomX Therapeutics, Inc. (CTMX)
3.295
+0.02
(+0.46%)
USD |
NASDAQ |
Aug 24, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price to Book Value : 2.377 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.366 |
| August 20, 2026 | 2.373 |
| August 19, 2026 | 2.575 |
| August 18, 2026 | 2.445 |
| August 17, 2026 | 2.489 |
| August 14, 2026 | 2.424 |
| August 13, 2026 | 2.417 |
| August 12, 2026 | 2.518 |
| August 11, 2026 | 2.489 |
| August 10, 2026 | 2.482 |
| August 07, 2026 | 2.496 |
| August 06, 2026 | 2.431 |
| August 05, 2026 | 2.417 |
| August 04, 2026 | 2.395 |
| August 03, 2026 | 2.287 |
| July 31, 2026 | 2.236 |
| July 30, 2026 | 2.366 |
| July 29, 2026 | 2.287 |
| July 28, 2026 | 2.323 |
| July 27, 2026 | 2.344 |
| July 24, 2026 | 2.337 |
| July 23, 2026 | 2.402 |
| July 22, 2026 | 2.402 |
| July 21, 2026 | 2.467 |
| July 20, 2026 | 2.539 |
| Date | Value |
|---|---|
| July 17, 2026 | 2.611 |
| July 16, 2026 | 2.644 |
| July 15, 2026 | 2.655 |
| July 14, 2026 | 2.640 |
| July 13, 2026 | 2.669 |
| July 10, 2026 | 2.712 |
| July 09, 2026 | 2.853 |
| July 08, 2026 | 2.763 |
| July 07, 2026 | 2.77 |
| July 06, 2026 | 2.748 |
| July 02, 2026 | 2.756 |
| July 01, 2026 | 2.597 |
| June 30, 2026 | 2.705 |
| June 29, 2026 | 2.545 |
| June 26, 2026 | 2.313 |
| June 25, 2026 | 2.225 |
| June 24, 2026 | 2.259 |
| June 23, 2026 | 2.143 |
| June 22, 2026 | 2.068 |
| June 18, 2026 | 2.007 |
| June 17, 2026 | 2.014 |
| June 16, 2026 | 1.994 |
| June 15, 2026 | 2.068 |
| June 12, 2026 | 2.048 |
| June 11, 2026 | 2.028 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.702 |
| Ocugen, Inc. | -- |
| iBio, Inc. | 0.6237 |
| Cardiff Oncology, Inc. | 2.574 |
| Capricor Therapeutics, Inc. | 1.607 |
Price to Book Value Related Metrics
| PS Ratio | 32.92 |
| Price | 3.295 |
| Earnings Yield | -13.87% |
| Market Cap | 717.98M |